Filing Details
- Accession Number:
- 0001104659-22-014375
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-08 18:00:30
- Reporting Period:
- 2022-02-04
- Accepted Time:
- 2022-02-08 18:00:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1875558 | Nuvectis Pharma Inc. | NVCT | Pharmaceutical Preparations (2834) | 862405608 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1896056 | Shay Shemesh | C/O Nuvectis Pharma, Inc. 1 Bridge Plaza, Suite 275 Fort Lee NJ 07024 | Chief Development Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.00001 | Acquisiton | 2022-02-04 | 2,100 | $3.38 | 1,178,769 | No | 4 | P | Direct | |
Common Stock, Par Value $0.00001 | Acquisiton | 2022-02-07 | 846 | $3.47 | 1,179,615 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- Reflects the weighted average purchase price. The range of prices for the shares purchased was $3.31 to $3.44. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
- Includes 48,399 shares of restricted stock.
- Reflects the weighted average purchase price. The range of prices for the shares purchased was $3.43 to $3.49. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
- Includes 48,399 shares of restricted stock.